American Federation for
MIDWESTERN REGION Edition
900 Cummings Center,
Beverly, MA 01915
Tel. (978) 927-8330
Fax: (978) 524-0498
It is a great pleasure to provide an update into the activities of the Mid-West Section of the AFMR. Congress and the White House are in the process of hammering out a budget for the fiscal year. Biomedical research at least in the House of Representative proposal faces severe cutbacks as do many other programs that are not related to defense, social security, or Medicare. It is during times like this that the mission of the AFMR is even more important. The mission of AFMR is to promote understanding of recent advances in biomedical science for the prevention, diagnosis and treatment of disease; to facilitate the exchange of ideas and information among physicians and other investigators who are concerned with the treatment of disease; and to improve health by fostering research in all medical disciplines through public policy initiatives and educational programs. Our Mid-West Regional Meeting in Chicago (April 14-15) co-chaired with the Central Society of Clinical Research supports our mission and promises to be an exciting multi-disciplinary meeting. We kick off on Thursday with our annual Career Development Workshop. We have two outstanding speakers in Joe Doty who is Vice Chair, Administration, Department of Medicine at Duke University who will provide an administratorís perspective on an investigative career in academic medicine and Dr. Ellen Seely from the Brigham who will provide an interactive presentation on creating mentoring networks to optimize career development. Although we gear these workshops for trainees and junior faculty, we know that these two speakers will provide information that will be of interest to even more senior attendees. On Friday, we will have the privilege of having Dr. Kenneth Polonsky, Dean of the Division of Biological Sciences and the Pritzker School of Medicine, deliver the Keynote Presentation. Although the abstract deadline has passed, it is not too late to register and attend this outstanding regional meeting. I look forward to seeing many of you in Chicago.
Abraham Thomas, MD MPH
Chair, MWAFMR The AFMR has taken recent steps toward advancing its public policy agenda by partnering with FASEB and with Research!America. Here are a few:
FASEB provided comments to the Department of Health and Human Services on proposed changes to the HIPAA Privacy Rule.
The AFMR identified priorities for future investment in biomedical research that were forwarded to the White House Office of Science and Technology Policy by FASEB.
AFMR Recommendations for Federal Investment in Biomedical Research
Submitted to the White House
FASEB comments on the Department of Health and Human Services (HHS) Notice of Proposed Rule Making (NPRM) regarding "Modifications to the HIPAA Privacy, Security, and Enforcement Rules Under the Health Information Technology for Economic and Clinical Health Act"
Congress has recessed without passing the FY2011 funding bills for NIH and other agencies. The Continuing Resolution is based on FY2010 levels and does not include the $1 billion NIH increase that President Obama proposed. When lawmakers return in November, FASEB will mobilize the community to press Congress to pass legislation that includes the higher NIH and NSF funding levels. The Journal of Investigative Medicine publishes work of broad interest to academic physicians and research scientists in areas pertaining to clinical and biomedical research.
Publications Upcoming in Issue #5:
EB symposium manuscripts
A collection of manuscripts summarizing the topics of the presentations at the AFMR EB symposium entitled "Translating Your Ideas: Drug Development, Intellectual Property and the State of Academic-University Relations". The manuscripts from this symposium detail pathways and problems that surround the process of translating scientific ideas and discoveries into beneficial treatments for patients. The papers provide an overview of the drug development process, beginning with approaches to innovation and the selection of promising ideas for development, through to the steps in drug assessment and clinical trials. They also examine issues of technology transfer for individual researchers, academic institutions, government funding sources and commercial entities, and issues of public trust and conflicts of interest in the current changing landscape of Academic-Industry collaborations.
Mason W. Freeman, Andrew P. Dervan, "The Path from Bench to Bedside: Considerations Before Starting the Journey".
Charles D. Smith, "Your Idea and Your University: Issues in Academic Technology Transfer".
Indrani Mukharji, "Patent & License Pearls and Pitfalls for Taking an Idea to the Marketplace".
Deborah Zucker, "Ethics and Technology Transfer: Patients, Patents and Public Trust".
Highlighted Original Contribution:
Susan Matulevicius, Laura C Huff, Lidia S Szczepaniak, Colby R Ayers, Matthew Budoff, Roderick McColl, Amit Khera, Ronald M Peshock, "The Potential of Electron Beam Computed Tomography for Coronary Artery Calcium Screening to Evaluate Fatty Liver: Comparison with 1H-MR Spectrocopy in the Dallas Heart Study". Data Mining: Functional Statistical Genetics & Bioinformatics - Laura Kelly Vaughan, PhD
Design and Analysis of Genome-Wide Association Studies - Tasha E. Fingerlin, PhD
Introduction to Epigenetics/Epigenomics - Xiangqin Cui, PhD
Pathway Analysis Hypothesis - David B. Allison, PhD
Copyright © 2020 American Federation for Medical Research. All Rights Reserved.